Transplant Microbiome Study Misses Engraftment Biomarker Endpoint

Nature Medicine published a prespecified companion study online November 12. Microbiome diversity at neutrophil engraftment did not predict one-year non-relapse mortality in the analyzed allogeneic HCT cohort, challenging a simple engraftment-diversity biomarker.




